In Les Snead’s office, behind the minimalist standing desk, opposite the bookshelf filled with volumes on greatness, process ...

A growing number of new studies have found that, at least for some cells, death isn’t the end, but the beginning of something ...

Up-to-date computational pipeline characterizes G-protein-coupled receptor (GPCR) repertoires in the closest relatives of metazoans, providing a framework to investigate the evolutionary origins and ...

All year long, these moments captivated the public, demonstrated dangerous trends, and pushed research and innovation forward ...

With studies of fossilized bones, gut contents, eggshells and more, paleontologists revealed new and captivating details ...

ImmunityBio's Anktiva wins conditional EMA approval, but faces stiff competition and financial risks. Click for why IBRX ...

When you hear the word gratitude the first impression you get is a tail-wagging dog. If you feed a dog one day, it will wag its tail even if you meet it after a few years. That is gratitude. In ...

Jurassic Park—and its never-ending sequels and spinoffs—starts with a basic premise: extracting the DNA of long-dead ...

As global attention focusses on high-stakes peace negotiations, a definitive Sri Lankan perspective on the promise and perils of negotiated conflict resolution comes to print At a moment when the ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced the planned expansion of its state-of-the-art manufacturing facility in Norton, Massachusetts. The Company is ...

Level, Macro-Level Share and Cite: Fuentes, A. (2025) Postgraduate EFL Writing with GenAI across Scientific Domains: A ...

The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...